Navigation Links
Carpentier-McCarthy-Adams IMR ETlogix Annuloplasty Ring

ProductsCarpentier-McCarthy-Adams IMR ETlogix Annuloplasty Ring
Company Edwards Lifesciences Corporation
Item Carpentier-McCarthy-Adams IMR ETlogix Annuloplasty Ring
Features 
  • Corrects for the valvular insufficiency associated with Type IIIb mitral regurgitation.
  • Decreased anteroposterior (AP) distance increases leaflet coaptation.
  • Asymmetric 3-D reduced P2-P3 curvature design compensates for tethered P3 segment.
  • Increased sewing margin in the P2-P3 region, marked with suture, designed to accommodate a double-suture row.
Description Current annuloplasty rings and bands are designed for symmetric dilatation. The IMR ETlogix ring is the first asymmetric ring designed to treat asymmetric dilatation.
Info Edwards Lifesciences Corporation
Customer Service: (800) 424-3278
Web site: http://www.edwards.com

Related medicine products :

1. Carpentier-Edwards Classic Tricuspid Annuloplasty Ring
2. Carpentier-Edwards Classic Mitral Annuloplasty Rings
3. Duran Annuloplasty System
4. SJM Tailor Annuloplasty Ring
5. SJM Seguin Annuloplasty Ring
6. ATS SIMULUS™ Annuloplasty Ring/Band
The Protract Hip System - Protract Standard Hip Stem
Performa Cemented Stem
Stability Cemented Stem
The Foundation 460 Series Cemented Stem
Medicine Products:
(Date:12/3/2009)..., Unfair Labor Practices, Protecting Donors, ...Dec. 3 Teamsters who wo...lities in Philadelphia went on strike this morning...th working conditions at these facilities that cou...of the blood supply, not to mention the wellbeing ...
(Date:12/3/2009)... The Lifestyle Advisors at Virt...fts to ease the stress of finding that perfect gif... DIY treatments in health, fitness and wellness th...n time and within budget. , ... mySpaShop (mSS), has gathered an assortment of ...
(Date:12/3/2009)... Insightra Medical, Inc, a Cali...d the launch of its new ventral hernia repair syst...ard sublay technique, which completely obviates th... , (PRWEB) December 3, 200...dical device company today announced the launch of...
(Date:12/3/2009)... , YOUNGTOWN, Ariz., Dec. 3 /PRNewswire-First...announced today that it has acquired SunView Care ...,s campus in Youngtown, Arizona, a sister communit...ity. The acquisition was effective December 1, 200...rnh/20071213/LATH168LOGO ) ,, "We are pleased ...
(Date:12/3/2009)...ington, DC The study of tobacco has been the life..., MD, deputy director of the Lombardi Comprehensiv...enter, has led the effort to edit a special-editio... ( CEBP ) dedicated to best research practices in..., The December issue of CEBP , a journal of the...
Breaking Medicine News(10 mins):Health News:Philadelphia Red Cross Blood Workers Strike to Protect Donor and Blood Safety 2Health News:Bring Spa Home for the Holidays at mySpaShop & Celebrate Recipes for Personal Spa Treatments 2Health News:Bring Spa Home for the Holidays at mySpaShop & Celebrate Recipes for Personal Spa Treatments 3Health News:Bring Spa Home for the Holidays at mySpaShop & Celebrate Recipes for Personal Spa Treatments 4Health News:Insightra Medical Launches the Freedom(TM) Ventral Hernia Repair, an Innovative New Way to Deploy Sublay Implants for Ventral Hernias Without Suturing 2Health News:Insightra Medical Launches the Freedom(TM) Ventral Hernia Repair, an Innovative New Way to Deploy Sublay Implants for Ventral Hernias Without Suturing 3Health News:Insightra Medical Launches the Freedom(TM) Ventral Hernia Repair, an Innovative New Way to Deploy Sublay Implants for Ventral Hernias Without Suturing 4Health News:The Ensign Group Acquires Arizona Skilled Nursing Facility 2Health News:Lombardi's Shields leads special journal focused on tobacco research 2
...ments can cause harmful side effect when combined ...ic supplements reduced// blood levels of the saqui...hibitors that are effective at slowing the progres...ne healthy, HIV-negative volunteers received saqui...
...ading to an alarming rise in liver cirrhosis cases... after having increased in men for some time//, Pr...e adds that females are showing signs of permanent... from getting worse.Among 35 to 44-year-olds, ther...
...er vascular diseases are the leading causes of dea...iction of stenotic, occlusive, aneurismal, inflamm... angiography and digital subtraction angiography (...h a very high spatial resolution and temporal reso...
...d Drugs Department is beginning to bare its fangs ...ied pharmacists, an offence under the Indian Drugs...ial sources, not only does this common practice je...lified pharmacists. Since anyone with a couple of ...
...eight will grow up to be overweight adults isn't e...ody mass index in childhood is very often reflecte... thinnest as children and fattest as adults tended...til the age of 15 years. The researchers collected...
...o suffer from dementia benefit from music therapy....atients playing instruments and making music. The ... patients and can help them to communicate. ... sufferers. If their results are positive, the sci...
Other Medicine News:Health News:Magnetic resonance angiography in clinical medicine 2
(Date:12/3/2009)...hina, Dec. 3 /PRNewswire-Asia/ -- Simcere Pharmace... SCR ), a leading pharmaceutical company,specializ...ng of branded,generic and proprietary pharmaceutic...od and Drug Administration ("SFDA") has initiated ...regarding human use rabies vaccine (vero,cell) man...
(Date:12/3/2009)...NKI, December 3 After two decades ...their field, Lightlake Therapeutics, experts,have ...nd gene testing,subjects for a trial of a simple, ...alth Organisation has described as a global epidem...hase II trial for the everyday treatment against o...
(Date:12/2/2009).... 2 Reportlinker.com announces tha... catalogue: ,, Cardiac Pacemakers - A World M...m/p0164335/Cardiac-Pacemakers---A-World-Market-Ana...ajor segment in a rapidly expanding cardiovascular...market is characterized by relatively mature condi...
Breaking Medicine Technology:Simcere Pharmaceutical Group Provides Update on Jiangsu Yanshen 2Simcere Pharmaceutical Group Provides Update on Jiangsu Yanshen 3Lightlake Therapeutics Inc Receives Ethical Approval to Begin Subject Selection for Future Phase II Clinical Trial for New Obesity Drug, in Helsinki, Finland 2Lightlake Therapeutics Inc Receives Ethical Approval to Begin Subject Selection for Future Phase II Clinical Trial for New Obesity Drug, in Helsinki, Finland 3Lightlake Therapeutics Inc Receives Ethical Approval to Begin Subject Selection for Future Phase II Clinical Trial for New Obesity Drug, in Helsinki, Finland 4Lightlake Therapeutics Inc Receives Ethical Approval to Begin Subject Selection for Future Phase II Clinical Trial for New Obesity Drug, in Helsinki, Finland 5Reportlinker Adds Cardiac Pacemakers - A World Market Analysis 2Reportlinker Adds Cardiac Pacemakers - A World Market Analysis 3Reportlinker Adds Cardiac Pacemakers - A World Market Analysis 4Reportlinker Adds Cardiac Pacemakers - A World Market Analysis 5Reportlinker Adds Cardiac Pacemakers - A World Market Analysis 6Reportlinker Adds Cardiac Pacemakers - A World Market Analysis 7Reportlinker Adds Cardiac Pacemakers - A World Market Analysis 8Reportlinker Adds Cardiac Pacemakers - A World Market Analysis 9Reportlinker Adds Cardiac Pacemakers - A World Market Analysis 10STEMCELL Technologies Inc Announces Release of Defined Animal Protein Free Maintenance Medium for hESCs and hiPSCs 59424 1STEMCELL Technologies Inc Announces Release of Defined Animal Protein Free Maintenance Medium for hESCs and hiPSCs 59424 2One Day Management Training Program to be Offered November 18 in Boston Area 59420 1One Day Management Training Program to be Offered November 18 in Boston Area 59420 2One Day Management Training Program to be Offered November 18 in Boston Area 59420 3One Day Management Training Program to be Offered November 18 in Boston Area 59420 4One Day Management Training Program to be Offered November 18 in Boston Area 59420 5New nanotech sensor developed with medical chemistry applications 14461 1New nanotech sensor developed with medical chemistry applications 14461 2